MyFinsight
Home
Blog
About
Contact
Proceeds from sale of
common stock, net of...
$3,693,470
Net cash provided by
financing activities
$3,592,299
Canceled cashflow
$101,171
Net increase in cash
$1,966,391
Canceled cashflow
$1,625,908
Payments of finance
agreement
$101,171
Prepaid expenses and
other current assets
-$138,627
Amortization
$50,412
Depreciation
$44,240
Accounts payable and
accrued expenses
$25,528
Stock-based compensation
expense
$24,733
Accounts receivable
-$3,852
Net cash used in
operating activities
-$1,562,212
Net cash used in
investing activities
-$63,696
Canceled cashflow
$287,392
Net loss
-$1,788,158
Patent costs incurred
$61,936
Purchases of property and
equipment
$1,760
Lease liability
-$61,446
Back
Back
Cash Flow
Cardio Diagnostics Holdings, Inc. (CDIO)
Cardio Diagnostics Holdings, Inc. (CDIO)
source: myfinsight.com